Introduction - FDA issued a guidance document in May 2007 that recommends that pharmaceutical manufacturers, repackers, and other suppliers of glycerin, and pharmacists who engage in drug compounding ensure that the glycerin they buy, sell, or use is not contaminated with diethelyene glycol (DEG), a poison. The FDA guidance also recommends specific analytical test methods that include a limit test for DEG.
While the FDA guidance focuses on the pharmaceutical industry, this may also concern many in the dietary supplement industry who use glycerin in extracts and other products.
Guidance & Methods of Analysis
2020 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.